Literature DB >> 26410768

ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICS.

D Förnvik1, K Lång2, I Andersson2, M Dustler3, S Borgquist4, P Timberg5.   

Abstract

This study aimed to investigate the growth rate of 31 consecutive invasive breast cancers based on volume measures on at least two serial mammograms and its relation to histopathological findings. The average tumour volume-doubling time in all invasive breast cancer subtypes was 282 d (range 46-749 d). Grade III breast cancers had a significantly shorter average tumour volume-doubling time of 105 d (range 46-157 d) compared with Grade I and II tumours (average of 296 d, range 147-531 d and average of 353 d, range 139-749 d, respectively) (p = 0.002). Multiple linear regression identified that tumour volume-doubling time was positively associated with patient age, histological grade and progesterone receptor expression and inversely associated with axillary lymph node involvement, human epidermal growth factor receptor 2 and Ki-67 expression (p < 0.001). In conclusion, tumour volume-doubling time as estimated on serial mammography may provide important prognostic information relevant for clinical decision-making.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26410768     DOI: 10.1093/rpd/ncv417

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  10 in total

1.  Development and evaluation of a method for tumor growth simulation in virtual clinical trials of breast cancer screening.

Authors:  Hanna Tomic; Anna Bjerkén; Gustav Hellgren; Kristin Johnson; Daniel Förnvik; Sophia Zackrisson; Anders Tingberg; Magnus Dustler; Predrag R Bakic
Journal:  J Med Imaging (Bellingham)       Date:  2022-06-06

2.  Correlation Factors Analysis of Breast Cancer Tumor Volume Doubling Time Measured by 3D-Ultrasound.

Authors:  Shuyin Zhang; Yan Ding; Qiaoying Zhou; Cheng Wang; Pengxi Wu; Ji Dong
Journal:  Med Sci Monit       Date:  2017-06-27

3.  Clonal replacement and heterogeneity in breast tumors treated with neoadjuvant HER2-targeted therapy.

Authors:  Jennifer L Caswell-Jin; Katherine McNamara; Johannes G Reiter; Ruping Sun; Zheng Hu; Zhicheng Ma; Jie Ding; Carlos J Suarez; Susanne Tilk; Akshara Raghavendra; Victoria Forte; Suet-Feung Chin; Helen Bardwell; Elena Provenzano; Carlos Caldas; Julie Lang; Robert West; Debu Tripathy; Michael F Press; Christina Curtis
Journal:  Nat Commun       Date:  2019-02-08       Impact factor: 14.919

4.  Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.

Authors:  Steven Habbous; Esha Homenauth; Andriana Barisic; Sharmilaa Kandasamy; Vicky Majpruz; Katharina Forster; Marta Yurcan; Anna M Chiarelli; Patti Groome; Claire M B Holloway; Andrea Eisen
Journal:  CMAJ Open       Date:  2022-04-05

5.  Robustness of radiomic features of benign breast lesions and hormone receptor positive/HER2-negative cancers across DCE-MR magnet strengths.

Authors:  Heather M Whitney; Karen Drukker; Alexandra Edwards; John Papaioannou; Milica Medved; Gregory Karczmar; Maryellen L Giger
Journal:  Magn Reson Imaging       Date:  2021-06-24       Impact factor: 3.130

6.  Molecular natural history of breast cancer: Leveraging transcriptomics to predict breast cancer progression and aggressiveness.

Authors:  Daniel J Cook; Jonatan Kallus; Rebecka Jörnsten; Jens Nielsen
Journal:  Cancer Med       Date:  2020-03-23       Impact factor: 4.452

7.  Radiological audit of interval breast cancers: Estimation of tumour growth rates.

Authors:  Emma G MacInnes; Stephen W Duffy; Julie A Simpson; Matthew G Wallis; Anne E Turnbull; Louise S Wilkinson; Keshthra Satchithananda; Rumana Rahim; David Dodwell; Brian V Hogan; Oleg Blyuss; Nisha Sharma
Journal:  Breast       Date:  2020-04-01       Impact factor: 4.380

8.  Cancer recurrence times from a branching process model.

Authors:  Stefano Avanzini; Tibor Antal
Journal:  PLoS Comput Biol       Date:  2019-11-21       Impact factor: 4.475

9.  VIRTUAL CLINICAL TRIALS IN MEDICAL IMAGING SYSTEM EVALUATION AND OPTIMISATION.

Authors:  Bruno Barufaldi; Andrew D A Maidment; Magnus Dustler; Rebecca Axelsson; Hanna Tomic; Sophia Zackrisson; Anders Tingberg; Predrag R Bakic
Journal:  Radiat Prot Dosimetry       Date:  2021-10-12       Impact factor: 0.972

10.  Has tumor doubling time in breast cancer changed over the past 80 years? A systematic review.

Authors:  Meryl Dahan; Delphine Hequet; Claire Bonneau; Xavier Paoletti; Roman Rouzier
Journal:  Cancer Med       Date:  2021-07-15       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.